Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clofibrate for lipid-induced hypertriglyceridemia and hypercholesterolemia in very low birth weight neonates
IRCT201108021162N18Phase 3Completed
- Sponsor
- Vice-chancellor for Research, Mashhad University of Medical Sciences
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of clofibride in hypertriglyceridemia and hypercholesterolemia, sponsored by Vice-chancellor for Research, Mashhad University of Medical Sciences. Primary endpoints: Serum triglyceride level and Serum cholesterol level. Started Jan 2006; status: completed.
02
Drugs
clofibride
03
Conditions
hypertriglyceridemiahypercholesterolemia
Beyond the preview
Go deeper on IRCT201108021162N18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201108021162N18.